Drug and Alcohol Dependence
|
|
- Erik Lawson
- 8 years ago
- Views:
Transcription
1 Drug and Alcohol Dependence 118 (2011) Contents lists available at ScienceDirect Drug and Alcohol Dependence j ourna l ho me pag e: Intensive referral to 12-step dual-focused mutual-help groups Christine Timko, Anne Sutkowi, Ruth C. Cronkite, Kerry Makin-Byrd, Rudolf H. Moos Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025, USA a r t i c l e i n f o Article history: Received 19 November 2010 Received in revised form 15 March 2011 Accepted 24 March 2011 Available online 22 April 2011 Keywords: Dual diagnosis Mutual-help groups Referral practices Substance use and mental health outcomes a b s t r a c t Background: This study implemented and evaluated procedures to help clinicians effectively refer dually diagnosed (substance use and psychiatric disorders) patients to dual-focused mutual-help groups (DFGs). Methods: Using a cohort cyclical turnover design, individuals with dual diagnoses beginning a new outpatient mental health treatment episode (N = 287) entered a standard- or an intensive-referral condition. Participants provided self-reports of 12-step mutual-help (DFG and substance-focused group [SFG]) attendance and involvement and substance use and psychiatric symptoms at baseline and six-month follow-up. The intensive referral intervention focused on encouraging patients to attend DFG meetings. Results: Compared to patients in the standard condition, those in the intensive referral intervention were more likely to attend and be involved in DFGs and SFGs, and had less drug use and better psychiatric outcomes at follow-up. Attending more intensive-referral sessions was associated with more DFG and SFG meeting attendance. More need fulfillment in DFGs, and more readiness to participate in SFGs, were associated with better alcohol and psychiatric outcomes at six months. However, only 23% of patients in the intensive-referral group attended a DFG meeting during the six-month follow-up period. Conclusions: The intensive referral intervention enhanced participation in both DFGs and SFGs and was associated with better six-month outcomes. The findings suggest that intensive referral to mutual-help groups focus on its key components (e.g., linking patients to 12-step volunteers) rather than type of group. Published by Elsevier Ireland Ltd. 1. Introduction Patients with both substance use and psychiatric disorders have high rates of posttreatment relapse and additional care episodes (Chen et al., 2006). Mutual-help groups, especially those in which psychiatric medications are recognized as useful, may provide an element of continuing care that improves dual diagnosis patients treatment outcomes (American Psychiatric Association, 1995). Most treated dual diagnosis patients are referred to 12-step substance-focused groups (SFGs) such as Alcoholics Anonymous (Humphreys, 1997). However, under usual referral, many dual diagnosis patients do not attend SFGs, and those who do often drop out quickly (Noordsy et al., 1996). Furthermore, although dual diagnosis patients benefit from SFGs, they may benefit more from 12-step dual-focused groups (DFGs) (Magura, 2008). This study implemented and evaluated a procedure to help treatment providers make effective referrals to DFGs. We examined whether intensive referral, compared to standard referral, increased dual diagnosis outpatients DFG and SFG attendance and Corresponding author. Tel.: x ; fax: address: ctimko@stanford.edu (C. Timko). involvement over a six-month follow-up period. We also determined whether patients who received intensive referral had better substance use and psychiatric outcomes. Finally, we examined links between better attendance at intensive referral sessions and 12-step group participation, and between more 12-step group participation and outcomes Dual-focused mutual-help groups Dually diagnosed individuals benefit from membership in DFGs, which are designed for persons who have both substance use disorders and mental illness (Laudet et al., 2004). Magura (2008) found that more frequent and sustained attendance at Double Trouble in Recovery was associated with better substance use, psychiatric, and personal functioning outcomes. Members considered the group important for recovery, partly because they felt free to talk about their mental illness and psychiatric medications. Consistently, dually diagnosed individuals with experience in DFGs were positive about the groups (Bogenschutz et al., 2002), and dual diagnosis patients who attended DFGs had significant improvements in global functioning and housing, and decreased hospitalizations, over two years (Hensley, 2004) /$ see front matter Published by Elsevier Ireland Ltd. doi: /j.drugalcdep
2 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Based on these studies and recommendations (Kelly et al., 2003; Sacks et al., 2008a; Westermeyer, 2006) that clinicians foster stable affiliation with DFGs, Bogenschutz (2005) piloted an intervention to help dually diagnosed individuals engage with Double Trouble in Recovery. The intervention modified 12-Step facilitation (Tonigan et al., 2002a,b) by addressing psychiatric issues, eliminating Step 4 (made an inventory of ourselves), assigning patients a case manager, giving rides to meetings, and introducing patients to a group member. Attendance at both DFGs and SFGs increased, and alcohol use and psychiatric symptoms decreased, during treatment. Although Bogenschutz (2005) and Magura (2008) studies indicate that dually diagnosed patients respond positively to DFGs, relatively few individuals treated for dual diagnoses attend DFGs, and little is known about the extent to which DFG attendance and involvement are associated with better outcomes (Kelly and Yeterian, 2008). In the short-term, dual-focused interventions may have more positive benefits for psychiatric than for substance use outcomes (Back et al., 2006a,b; Hien et al., 2010; Read et al., 2004; Sacks et al., 2008b) SFGs for dual diagnosis patients In debate about dually diagnosed patients participation in and benefit from SFGs (Bogenschutz et al., 2006; Ouimette et al., 2003), a concern is that SFGs emphasizing the primacy of addictions may invalidate patients perceptions of mental illness as the primary problem and increase their distress (Ouimette et al., 2001). SFGs may be perceived as objecting to psychotropic medications (Bogenschutz and Akin, 2000; Ortman, 2001) and SFG members may be seen as lacking empathy and acceptance (Magura, 2008; Mowbray et al., 1995). Dually diagnosed patients often fail to endorse the 12-step philosophy that they are powerless over substances (Handymaker et al., 2002; Luke et al., 2002), minimize their substance use (Jordan et al., 2002), and have difficulty accepting the idea of a Higher Power (Satel et al., 1993). Interpersonal avoidance associated with psychiatric disorders may also make membership and sponsorship in SFGs problematic (Jordan et al., 2002). Despite these concerns, dually diagnosed patients attend SFGs at rates approaching those of individuals with only substance use disorders (Westermeyer and Schneekloth, 1999). When dual diagnosis patients attend AA or NA, they benefit from participation (Chi et al., 2006; Ouimette et al., 2001; Timko and Sempel, 2004). However, these studies have focused primarily on associations of meeting attendance with substance use outcomes, and little on other aspects of SFG involvement, such as sponsorship and working the steps, or on psychiatric symptoms (Bogenschutz et al., 2006). In summary, dual diagnosis patients may benefit more from DFGs than SFGs. Because effective approaches for referral to DFGs are needed, we developed an intensive referral procedure. Dual diagnosis patients entering outpatient mental health treatment received either standard or intensive referral to DFGs, and were followed at six months to determine whether intensive referral resulted in more DFG and SFG attendance and involvement, and in better substance use and psychiatric outcomes. We also examined associations between intensive referral attendance and 12-step participation, and between 12-step participation and outcomes. 2. Methods 2.1. Sample Patients were included on the basis of: (1) entering outpatient mental health treatment at a Department of Veterans Affairs (VA) program in northern California, (2) identified by case managers as having dual substance use and psychiatric disorders based on the program s standard assessment procedures and medical record review (see Seal et al., 2007, 2010, regarding VA medical record diagnoses), and (3) screened by case managers as cognitively able to understand study procedures. Of 343 patients screened, 17 were ineligible and 39 refused to participate, leaving a sample of 287 individuals. Of the 287 patients, at six months, nine were deceased or incarcerated. An additional 57 were not located, or were located and either refused participation or did not participate in scheduled assessments. The six-month follow-up rate was 80% (N = 221) among patients still alive and not incarcerated. The followed and not-followed groups did not differ (using chi-square and t-tests) on condition or baseline characteristics (see Table 1 for a list) except that followed patients were somewhat better educated and less likely to be homeless (p <.05). The treatment was evidence-based (e.g., using Cognitive-Behavioral and Mindfulness approaches), multidisciplinary, and emphasized teaching skills (e.g., relapse prevention, symptom or stress management), typically in two group sessions per week. After being introduced to the study, participants provided written consent. Stanford University s Institutional Review Board approved study procedures Procedure Counselor training. Counselors (Social Workers, Addiction Therapists who provided treatment and both conditions; N = 5) attended a training that detailed the standard and intensive intervention protocols. In a practice phase, counselors were monitored by senior project staff while they implemented the interventions with patients who were training cases; their data were not analyzed for this report. Specifically, two groups per counselor were observed, rated, and supervised using the fidelity checklist (see below), and counselors were then certified Condition assignment. Patients were assigned to the intensive-referral (N = 142) or standard-referral (N = 145) condition using a recurrent institutional cycle design (Shadish et al., 2002). Under this design, the intensive and standard referral conditions were delivered in a group counseling format and run in alternate three-month periods over 12 months. The main reason for using the cycling design was that patients in the same program talk to each other and, under random assignment and simultaneous intensive and standard groups, would become aware that some were receiving intensive referral whereas others were not. This would have raised a risk of contamination between conditions (Kahler et al., 2004) Conditions Standard referral. In the standard referral condition, during the outpatient session after study entry, the counselor gave patients a schedule of local 12-step DFG meetings and used a standardized script to encourage attendance. Counselors were asked not to provide patients in the standard condition with components of intensive referral. They were not asked to refrain from referring patients to 12-step SFGs, which is the usual practice Intensive referral. The intensive referral condition included patients attendance at four additional outpatient group sessions within one month; four sessions kept the intervention brief yet allowed patients to build rapport. During Session 1, the counselor gave patients a schedule of local DFG meetings with specific directions to them, and reviewed a handout on DFG meetings from Dual Recovery Anonymous. The counselor elicited and discussed patients pros and cons of attending DFGs. At Session 2, the counselor asked if patients had questions about the handout. This session consisted mainly of a 12-step DFG orientation (Mueser et al., 2003). The counselor outlined what meetings are like and the group had a practice meeting. The counselor discussed group etiquette and patients role-played introducing themselves to someone new (Bellack et al., 1997; Mueser and Glynn, 1999). At Session 3, the counselor arranged for a DFG member to volunteer to come to the session. Volunteers gave a brief personal history and arranged to meet patients and attend a meeting together. At Session 4, the counselor asked patients if they had attended a DFG meeting; if not, the counselor helped the patient contact a volunteer by phone to arrange another opportunity to attend a meeting together. The counselor reviewed a handout (from Double Trouble in Recovery) on how and why to obtain a sponsor, provided a list of available local DFG sponsors, and explained how to obtain a temporary sponsor. The counselor addressed patients concerns about asking for and working with a sponsor and patients role-played (Bellack et al., 1997; Mueser and Glynn, 1999) asking someone to be a temporary sponsor Fidelity Patients completed checklists rating each of the four group sessions. When ratings were aggregated across sessions, most participants indicated having received the main components of the intensive referral intervention: e.g., did the group talk about going to 12-step meetings (100% said yes); counselors checked that patients had local DFG meeting schedules (100%); counselors reviewed the DFG handout (100%); group discussed pros and cons of different self-help groups (100%); group role-played introductions to someone new (97%); group practiced a DFG meeting (98%); DFG volunteer visited (97%); patient agreed to attend a DFG meeting with the volunteer (98%); group discussed getting a DFG sponsor (100%); and counselors gave patients a list of DFG sponsors (80%). In addition, observers rated intensive sessions as to whether they delivered their key components; ratings ranged from
3 196 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Table 1 Comparisons of patients in the standard- or intensive-referral condition on baseline characteristics. Standard Intensive X 2 (p) t(p) Overall Sample Percent male (.44) 90.9 Percent Caucasian (.31) 48.8 Mean age (SD) 51.2(8.8) 50.9(9.0).28(.78) 51.0(8.9) Mean years education (SD) 13.4(1.8) 13.5(1.8).65(.52) 13.5(1.8) Percent employed (.10) 45.5 Percent married (.42) 10.5 Percent homeless (.62) 31.7 Percent diagnosed with: a Major depression, mood disorder (.64) 62.7 PTSD (.91) 36.2 Other anxiety disorder (.17) 22.6 Schizophrenia, schizoaffective disorder (.76) 11.8 Bipolar disorder (.55) 12.9 Percent diagnosed with: 2.91(.23) Alcohol use disorder only Drug use disorder only Alcohol and drug use disorder Mean ASI composite score (SD): Alcohol.157(.230).190(.213) 1.24(.21).174(.222) Drugs.068(.085).079(.083) 1.11(.27).073(.084) Psychiatric.404(.201).408(.191).16(.87).406(.196) Mean no. of days use in past 30 (SD) Alcohol 10.0(5.7) 8.4(5.7).87(.38) 9.3(5.7) Drugs 16.8(9.0) 17.4(9.1).88(.41) 17.1(9.1) Mean no. psychiatric symptoms (SD) 2.1(1.4) 2.2(1.4).55(.58) 2.2(1.4) Mean importance, additional psychiatric treatment 2.7(1.5) 2.9(1.4) 1.31(.19) 2.7(1.5) Mean medication adherence (SD) 1.4(1.3) 1.4(1.2).33(.75) 1.4 (1.3) Percent attended DFG, lifetime (.74) 22.6 Percent attended DFG, past two years (.70) 17.1 Mean no. DFG meetings, lifetime (SD) 3.3(11.5) 1.8(5.9) 1.45(.11) 2.5(9.2) Mean no. DFG meetings, past two years (SD) 1.2(3.9).8(2.9).90(.18) 1.0(3.4) Percent attended SFG, lifetime (.26) 97.6 Percent attended SFG, past two years (.42) 91.6 Mean no. SFG meetings, lifetime (SD) 458.9(874.1) 524.5(1148.1).55(.59) 491.3(1017.7) Mean no. SFG meetings, past two years (SD) 95.3(142.4) 71.6(105.8) 1.60(.11) 83.5(125.9) a Total percentage is >100% because some patients were diagnosed with more than one disorder. 75% (Session 4: role-played asking for a sponsor) to 100% for most components (e.g., Session 3: visit by DFG volunteer) Measures Baseline. Self-report data, including demographics, previous mutual-help group utilization, and substance use and psychiatric status, were collected from patients at intake DFG and SFG participation. At baseline, patients reported whether they had attended any DFG meetings in their lifetime and during the past two years, and if so, how many. Patients were reminded that DFGs are for people with both mental illness and substance abuse, and include groups such as Dual Recovery Anonymous and Double Trouble in Recovery. At baseline, patients reported on whether they had attended any SFG meetings in their lifetime and during the past two years, and if so, how many. They were reminded that SFGs include Alcoholics Anonymous and Narcotics Anonymous, and not the DFGs asked about before. Support is good for the reliability and validity of self-reports regarding mutual-help group participation (Morgenstern et al., 1997; Tonigan et al., 2002a,b; Walitzer et al., 2009) Substance use and psychiatric status. The Addiction Severity Index (ASI) (McLellan et al., 1985a,b), a structured clinical research interview, assessed alcohol use, drug use, and psychiatric functioning. In each area, questions focus on the number and duration of symptoms in the patient s lifetime and past 30 days (McKay et al., 1994). ASI composites range from 0 to 1, with higher scores indicating poorer outcomes. Studies support the validity of self-reports of alcohol and drug use (Babor et al., 1987; Calhoun et al., 2000; Darke, 1998; Hersh et al., 1999) and psychiatric symptoms (Herman et al., 2002; Kirsner et al., 2003; Ready et al., 2002; Voruganti et al., 1998). We also used two clinically-relevant ASI measures of substance use status, and two of psychiatric status. For substance use, we used the number of days patients used alcohol, and used drugs, in the past 30. For psychiatric status, one measure was the count of six symptoms measured dichotomously (0 = no, 1 = yes) that patients reported in the past month (e.g., serious depression, serious anxiety/tension). For the other measure, patients rated the importance of additional treatment for their psychological problems (0 = not at all, 4 = extremely) Medication adherence. Patients completed the four-item Medication Adherence Questionnaire (e.g., When you feel better do you sometimes stop taking your medicine? Yes/No; alpha =.74) (Thompson et al., 2000). Lower scores indicate better adherence. Self-reports of medication adherence are valid and reliable (DiMatteo, 2004; Garber et al., 2004; Sirey et al., 2001) Follow-up. The six-month telephone follow-up was conducted by trained research assistants blinded to patients condition. It covered DFG and SFG participation, and substance use and psychiatric outcomes. ASI follow-up interviews are conducted validly and reliably over the telephone (Fureman et al., 1990) DFG participation. To measure 12-step DFG attendance and involvement, we used the AA Inventory (Tonigan et al., 1996, 2002a,b) and the AA Affiliation Scale (Humphreys et al., 1998). We replaced items use of AA with 12-step dual-focused self-help group, and specified to what the latter term referred. Items are listed in Table 2; for dichotomous items, no = 0 and yes = 1. Toward the top of Table 2, four composites are listed: (1) overall involvement, which is the sum of the 14 involvement items (alpha =.91), (2) number of DFG steps worked, (3) need fulfillment in DFGs attended (alpha =.86), and (4) readiness for DFG participation (alpha =.96). Need fulfillment was the sum of five items (e.g., extent to which group meetings met your needs) rated on a 0 to 3 scale; higher scores represented more fulfillment. Readiness was the sum of six items (e.g., how ready are you to attend a DFG, work the steps, obtain a sponsor) rated 1 = not ready, 2 = thinking about, 3 = ready, or 4 = already doing; higher scores represented greater readiness to participate in DFGs SFG participation. Procedures to measure SFG attendance and involvement paralleled those for DFG participation (see Table 3). Patients were reminded about
4 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Table 2 Comparisons of patients in the standard- or intensive-referral condition on dualfocused group (DFG) attendance and involvement at the six-month follow-up. Standard Intensive X 2 /t DFG attendance Attended meeting (percent) a * Number of meetings 3.7 (3.3) 9.7 (8.9) 2.70 ** attended (mean, SD) DFG involvement Overall involvement (mean, 4.3 (2.6) 5.4 (3.1) 1.18 SD) No. steps worked (mean, SD).8 (1.4) 2.7 (3.5) 2.45 * Needs fulfillment in groups 8.6 (4.0) 9.6 (2.7).89 (mean, SD) Readiness (mean, SD) 6.5 (2.4) 7.3 (2.5) 1.08 DFG involvement items (percent) Read literature Shared honestly at meetings Socialized with group peers Read out loud at a meeting Did service at meetings Gave a talk at a meeting Had a spiritual awakening Consider self to be a group ** member Made phone calls to group peers Celebrated a sobriety birthday * Called a member for help Chaired a meeting Attended 90 meetings in days Have a sponsor 0 0 * p <.05, ** p <.01. a Analysis for this variable used all participants; otherwise, analyses used participants who went to a DFG meeting. the groups referred to (e.g., AA, NA). Alphas were.92,.83, and.95 for overall involvement, need fulfillment from SFGs attended, and readiness, respectively Substance use and psychiatric status. The ASI provided composite scores on patients alcohol and drug use and psychiatric functioning at the six-month followup. Participants were also asked how many days out of the past 30 they had used alcohol and drugs. No use of alcohol or drugs was classified as abstinent; and any use as not abstinent. Psychiatric status was measured, as at baseline, by the count of six psychiatric symptoms reported, and patients perceived need of additional help for psychiatric problems Medication adherence. Medication adherence was assessed at follow-up as at baseline Analysis After comparing the standard and intensive referral groups at baseline on demographic and diagnostic characteristics, psychiatric and substance use status, and prior DFG and SFG attendance (N = 287, all baseline participants), we compared the groups on DFG and SFG attendance and involvement at follow-up by conducting chisquare analyses and t-tests (N = 221, all participants followed). We also compared patients in the standard and intensive referral groups on substance use and psychiatric outcomes at follow-up by conducting Analyses of Covariance; the covariate was the baseline value of the outcome. We used correlations to examine associations between attending intensive referral sessions and six-month indices of DFG and SHG participation. Regressions were also conducted predicting ASI alcohol, drug, and psychiatric composite scores at six months, entering the baseline value of the composite and condition (block 1), an indicator of DFG or SFG participation (block 2), and the interaction between condition and the block 2 indicator (block 3). Table 3 Comparisons of patients in the standard- or intensive-referral condition on substance-focused group (SFG) attendance and involvement at the six-month follow-up. Standard Intensive X 2 /t SFG attendance Attended meeting (percent) a ** Number of meetings attended (mean, SD) 54.9 (44.9) 73.7 (97.3) 3.73 * SFG involvement Overall involvement (mean, 7.9 (3.2) 8.1 (3.2).25 SD) No. steps worked (mean, SD) 3.1 (3.9) 4.2 (3.3) 1.84 * Needs fulfillment in groups 11.0 (2.8) 11.1 (2.8).28 (mean, SD) Readiness (mean, SD) 9.4 (2.3) 9.5 (2.5).30 SFG involvement items (percent) Read literature Shared honestly at meetings Socialized with group peers Read out loud at a meeting Did service at meetings Gave a talk at meetings Had a spiritual awakening Consider self to be a group member Made phone calls to group peers Celebrated a sobriety birthday Called a group member for help Chaired a meeting Attended 90 meetings in days Have a sponsor * p <.05 ** p <.01. a Analysis for this variable used all participants; otherwise, analyses used participants who went to a SFG meeting. unemployed. Few patients were married, and almost one-third were homeless. At baseline, the most common psychiatric diagnosis was major depression, followed by PTSD, other anxiety disorders, schizophrenia, and bipolar disorder (Table 1). In addition, patients were most likely to have both alcohol and drug use disorders; the main drugs of choice were cocaine, cannabis, and amphetamines. There were no group differences on alcohol, drug, or psychiatric severity or medication adherence. At baseline, the two groups did not differ on lifetime or recent DFG meeting attendance (Table 1). Across groups, less than onequarter of patients had ever attended a DFG meeting; they had attended an average of only 2.5 such meetings in their lifetime. DFG attendance in the past two years was quite low. At baseline, the two groups also did not differ on lifetime or recent SFG meeting attendance (Table 1). In contrast to DFG participation, almost all patients had ever attended a SFG meeting; they had attended an average of almost 500 meetings in their lifetime. In addition, over 90% of patients had attended a SFG meeting in the past two years, with an average of more than 80 meetings during that period. 3. Results 3.1. Baseline characteristics There were no differences between patients in the standard and intensive referral groups on baseline demographic or clinical characteristics (Table 1). The sample was mainly male, non-white, middle aged, and, despite having had some college education, 3.2. DFG and SFG participation at follow-up At the six-month follow-up, a higher proportion of patients in the intensive-referral group attended a DFG meeting; however, even among these patients, only 23.1% did so, compared to 13.5% in the standard group (Table 2). Among patients who attended a DFG, intensive-referral patients attended more DFG meetings than standard referral patients did. They also worked more dual-focused
5 198 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Table 4 Comparisons of patients in the standard or intensive referral condition on outcomes at six months controlling for the corresponding outcome at baseline. Standard Intensive F ASI composite (mean, SD) Alcohol.111 (.171).095 (.178).58 Drugs.037 (.060).030 (.059).88 Psychiatric.387 (.228).333 (.199) 4.87 ** Number of days used in past 30 (mean, SD) Alcohol 1.83(6.17) 1.31(4.56).61 Drugs 2.36(7.51).66(2.66) 3.75 * Abstinent (percent) Alcohol Other drugs Alcohol and other drugs Psychiatric status No. of symptoms 2.2 (1.5) 1.8 (1.4) 3.87 * Medication adherence (mean, SD) 1.1 (1.1) 1.1 (1.1).08 Need additional help (mean, SD) 1.9 (1.6) 1.4 (1.6) 4.54 * * p <.05, ** p <.01. Note: Adjusted means are displayed. program steps and were more likely to consider themselves a DFG member, and to have celebrated a sobriety birthday with a DFG. A higher proportion of patients in the intensive-referral group attended a SFG meeting (Table 3). Among patients who attended a SFG, intensive-referral patients attended more SFG meetings. However, the groups did not differ on SFG involvement, except that intensive-referral patients worked more of the 12 steps. The regressions showed that whether or not a DFG meeting was attended (analyses included all patients followed at six months), or number of DFG meetings attended (analyses included only patients who attended a DFG meeting) did not predict ASI composite scores at six months (with ASI scores at baseline and condition controlled). In addition, few indices of DFG involvement predicted ASI composite scores at follow-up (controlling for ASI baseline scores and condition). Calling another DFG member for help (b =.190) and more need fulfillment in DFGs (b =.315) were associated with a better psychiatric outcome (p <.05). In addition, more need fulfillment was associated with a better alcohol outcome (b =.246, p <.05). The interactions of condition by need fulfillment in DFGs (b =.401, p <.01), and by readiness to attend DFGs (b =.276, p <.05), predicted psychiatric outcomes. For patients in the intensive condition, more need fulfillment was related to better psychiatric outcomes (b =.517, p <.05), but this was not observed for patients in the standard condition (b =.161, p >.05). Similarly, for patients in the intensive condition, more readiness was related to better psychiatric outcomes (b =.229, p <.05), but this did not hold for patients in the standard condition (b =.039, p >.05). Regressions also showed that whether or not a SFG meeting was attended, or number of SFG meetings attended, did not predict ASI composite scores at six months (with ASI scores at baseline and condition controlled). When involvement indices were used as predictors, more readiness to attend SFG meetings was related to better psychiatric functioning (b =.114, p <.05). Greater readiness to attend SFGs (b =.163; p <.01) was also related to better alcohol outcomes, as was being more involved overall with SFGs (b =.198, p <.05). On involvement items, having celebrated a sobriety birthday (b =.124), telephoning group members (b =.129), and having a sponsor (b =.132) were associated with better alcohol outcomes (p <.05). Interactions of condition by SFG participation were not significant predictors of ASI composite scores. In regressions with a significant 12-step group participation predictor, adjusted R 2 s ranged from.18 to.26 (p <.05) 3.3. Substance use and psychiatric outcomes At six months, with baseline scores controlled, the groups did not differ on the ASI alcohol or drug composite, but patients in the intensive referral group had less severe psychiatric problems (Table 4). Similarly, patients in the intensive referral group had fewer psychiatric symptoms and stated that they were less in need of additional treatment for psychiatric problems. Finally, intensivereferral patients used drugs for a fewer number of days Intensive referral attendance and DFG and SFG participation Of patients assigned to the intensive referral condition, all attended at least one session (Mean = 2.6 sessions, SD = 1.1); 24.2% attended one session, 23.2% attended two, 26.3% attended three, and 26.3% attended all four. We examined associations between attending more intensive referral sessions and six-month indices of DFG and SHG participation: attended at least one meeting; number of meetings attended; overall involvement; number of steps worked; need fulfillment; and readiness. More attendance at intensive referral sessions was associated with attending at least one DFG meeting (r =.189, p <.05) and greater readiness to attend DFG meetings (r =.177, p <.05). It was also associated with attending more SFG meetings (r =.234, p <.01) and being more involved overall in SFGs (r =.169, p <.05) DFG and SFG participation and outcomes 4. Discussion Compared to patients receiving standard referral, a higher proportion of dually diagnosed patients receiving intensive referral to DFGs attended a DFG meeting over the next six months. In addition, patients in the intensive referral group who went to at least one DFG meeting attended more such meetings than did patients in the standard referral group. However, only about one-quarter of patients in the intensive referral group attended a DFG meeting, and patients who did attend went to an average of only 10 meetings over six months. In contrast, the majority of patients in both the intensive and standard referral conditions attended SFGs over the six-month follow-up period. Nevertheless, patients in the intensive referral group were more likely to attend SFGs and attended more SFG meetings. The standard referral group attended an average of two meetings per week, whereas the intensive referral group attended an average of three meetings per week Why didn t intensive referral patients participate more in DFGs? In light of the strong fidelity with which the intensive referral condition was delivered, along with good attendance at intensive referral sessions, it is surprising that only a minority of patients participated in DFGs. In hindsight, we attribute the lack of greater participation to aspects of the intervention and of the DFGs themselves. Regarding the intervention, discussing the cons as well as the pros of attending mutual help groups may have dissuaded some participation. As framed by motivational interviewing (Miller and Rose, 2009), clients monitor their speech for clues about their attitudes and intent to change. If they focus on reasons against engaging in a specific behavior (attending DFGs), they may infer that they do not want to engage in the behavior and become less likely to do so (Moyers et al., 2007, 2009). Also, the intensive referral intervention s emphasis on DFG attendance was not carried over into other components of patients outpatient treatment, which may have lessened the intervention s impact.
6 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) The relative lack of easily accessible DFG meetings likely contributed to the low participation rate. There were only about eight Dual Recovery Anonymous groups meeting regularly in the county in which this study was located, compared to about 205 AA groups. Similarly, Magura (2008) found that individuals dropped out of Double Trouble in Recovery mainly because regular meetings were discontinued or took place at inconvenient locations. In light of 12- step program recommendations to try different groups to attain a good fit, the low number of DFGs relative to SFGs decreased the options for patients to find a comfortable match. Another point is that AA and other SFGs may have become increasingly supportive of members with co-occurring mental illnesses, their use of psychiatric medications, and discussion of mental health-related issues (Laudet, 2008). Accordingly, patients in our sample, relatively few of whom were diagnosed with schizophrenia, may not have seen the need to attend specialized DFGs. In addition, whereas SFGs are truly peer-run, the DFG meetings available to patients were often led by individuals who, although dually diagnosed themselves, were formally affiliated with the facility in which the meeting was located and so may not have been perceived as peers. Although the intensive referral intervention did not yield high rates of participation in DFGs, it did result in more patients attending SFGs, and more attendance and involvement in SFGs. That is, preparing for DFG participation through intensive referral appeared to generalize to SFG participation. Because intensive referral involved reviewing 12-step philosophy and the 12 steps and identifying potential areas of difficulty, such as emotional discomfort, that may arise during meetings, dually diagnosed patients who received the intervention may have experienced SFGs as less alienating and more empathic about problems of living with psychiatric disabilities (Mueser et al., 2003; Noordsy et al., 1996). Another consideration is that study participants had very high SFG exposure at baseline, and it is unclear how this might have affected their openness to more engagement in SFGs or DFGs (Kaskutas and Subbaraman, 2010). Treatment programs that explain and prime individuals for mutual help may be especially effective at helping patients benefit from those groups (Humphreys et al., 1999). That is, when treatment staff educate (or re-educate) dually diagnosed patients about mutual-help concepts, and provide access to meetings and role models during treatment, these patients may find mutual-help groups, whether dual- or substance-focused, to be a logical, comfortable extension of treatment. Thus, during-treatment exposure to mutual-help groups, together with discussions about general principles underlying these groups, may promote mutual-help participation (Timko and DeBenedetti, 2007) Intensive referral, 12-step participation, and outcomes Patients receiving intensive referral had consistently better sixmonth psychiatric outcomes but only one better substance-related outcome. This finding is in line with results of prior investigations of enhanced interventions for dually diagnosed patients (Hien et al., 2010; Sacks et al., 2008b). In addition to increased attendance at DFGs and SFGs, patients receiving intensive referral worked more DFG and SFG steps and were more likely to consider themselves members of a DFG and to have celebrated a sobriety birthday. Moreover, better psychiatric outcomes were associated with calling another DFG member for help, more need fulfillment in DFGs, and more readiness to attend SFG meetings. Better alcohol outcomes were also associated with more need fulfillment in DFGs, as well as greater readiness to attend SFG meetings, and more involvement with SFGs, especially celebrating a sobriety birthday, making phone calls to other group members, and having a sponsor. Each of these aspects of mutual-help group participation is an indicator of proposed 12-step group mechanisms of change (Moos, 2008). Proposed active ingredients of 12-step groups, both DFGs and SFGs, are support, goal direction, and structure; abstinence-oriented norms and role models; engagement in rewarding activities; and bolstering self-efficacy and coping skills (Bogenschutz, 2007; Moos, 2008). The 12-step group behaviors and experiences associated with the intensive-referral intervention and better psychiatric and alcohol outcomes are consistent with these higher-order active ingredients. For example, readiness to attend and more involvement are indicators of bonding, having a sponsor is associated with exposure to an abstinence-oriented model and norms, calling a group member for help reflects coping skills, and having a sobriety birthday is an indicator of self-efficacy. Once the higher-order active ingredients of mutual-help groups can be measured, it will be possible to examine how well and consistently different types of DFGs and SFGs deliver them, and the extent to which they are associated with outcomes for dually diagnosed and other groups of individuals Limitations and conclusions A limitation of this study is that all patients were treated within the VA, which is federally funded and operates the largest mental health treatment system in the US. Generally, VA substance abuse and other mental health services are of similar quality and effectiveness to those in the private sector (Asch et al., 2010; Rosenheck et al., 2000). However, the VA patient population has poorer health status compared with the general patient population (Agha et al., 2000; Grella et al., 2010). The extent to which our findings will be replicated in studies of patients in other health care systems remains to be determined. Also, this was not a randomized controlled trial; however, the two groups were closely comparable, and the cycling design avoided the likelihood that patients in the two conditions would perceive that they were obtaining nonequivalent treatments. Further, the study was limited by having a single follow-up focusing on the prior 30 days, and conducting multiple comparison tests with the risk of spurious differences between conditions. Our results suggest that, by incorporating intensive referral procedures into treatment, providers can increase the likelihood that dually diagnosed patients will participate in mutual-help groups and continue to improve after treatment has ended. Given the benefit that dually diagnosed patients appear to gain from participating in SFGs (Timko and Sempel, 2004), and SFGs widespread availability, treatment providers should link patients to 12-step group volunteers and consistently ask patients about their meeting participation. If a dual diagnosis patient is uncomfortable in a SFG, special procedures could be followed to identify and access a suitable DFG. Intensive referral could emphasize the common benefits of mutualhelp group participation, such as support, direction, and structure; abstinence-oriented role models and norms; and opportunities for rewarding activities, bolstering self-efficacy, and learning new coping skills (Bogenschutz, 2007; Moos, 2008). Role of funding source This work was supported by the Department of Veterans Affairs (VA) Office of Research and Development (Health Services Research & Development Service, IIR , RCS , and RCS ), and the VA Office of Academic Affiliations (TPP ). The funding agencies had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The views expressed here are the authors and do not necessarily represent the views of the Department of Veterans Affairs.
7 200 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Contributors Christine Timko, Ruth Cronkite, and Rudolf Moos designed the study and directed the statistical analyses. Anne Sutkowi managed the study and set up the data. Kerry Makin-Byrd helped with data analysis and wrote the first manuscript draft using these data. All authors contributed to and approved the final manuscript. Conflicts of interest There are no conflicts of interest. Acknowledgements We thank Akash Desai, Stacy Lin, Daniel Kaplan, Susan Macus, and Cassandra Snipes for help with the study. References Agha, Z., Lofgren, R.P., VanRuiswyk, J.V., Layde, P.M., Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch. Intern. Med. 160, American Psychiatric Association, Practice guidelines for the treatment of patients with substance abuse disorders. Am. J. Psychiatry 152, Asch, S., Glassman, P., Matula, S., Trivedi, A., Miake-Lye, I., Shekelle, P., Comparison of quality of care in VA and non-va settings: A systematic review. Department of Veterans Affairs, Greater Los Angeles Health Care System, Los Angeles. Babor, T.F., Cooney, N.L., Lauerman, R.J., The dependence syndrome concept as a psychological theory of relapse behaviour: an empirical evaluation of alcoholic and opiate addicts. Br. J. Addict. 82, Back, S.E., Brady, K.T., Jaanimagi, U., Jackson, J.L., 2006a. Cocaine dependence and PTSD: a pilot study of symptom interplay and treatment preferences. Addict. Behav. 31, Back, S.E., Brady, K.T., Sonne, S.C., Verduin, M.L., 2006b. Symptom improvement in co-occurring PTSD and alcohol dependence. J. Nerv. Ment. Dis. 194, Bellack, A.S., Mueser, K.T., Gingerich, S., Agresta, J., Social Skills Training For Schizophrenia: A Step-By-Step Guide. Guilford Press, NY. Bogenschutz, M.P., Specialized 12-step programs and 12-step facilitation for the dually diagnosed. Community Ment. Health J. 41, Bogenschutz, M.P., step approaches for the dually diagnosed: mechanisms of change. Alcohol. Clin. Exp. Res. 31, 64s 66s. Bogenschutz, M.P., Akin, S.J., Step participation and attitudes toward 12- step meetings in dual diagnosis patients. Alcohol Treat. Q. 18, Bogenschutz, M.P., Vigil, J., Arenella, P., Attitudes of Dually Diagnosed Patients Toward Double Trouble in Recovery and Traditional 12-Step Programs. In: Poster 3, American Academy of Addiction Psychiatry 13th Annual Meeting and Symposium, Las Vegas, NV. Bogenschutz, M.P., Geppert, C.M., George, J., The role of 12-step approaches in dual diagnosis treatment and recovery. Am. J. Addict. 15, Calhoun, P.S., Sampson, W.S., Bosworth, H.B., Feldman, M.E., Kirby, A.C., Hertzberg, M.A., Wampler, T.P., Tate-Williams, F., Moore, S.D., Beckham, J.C., Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder. J. Consult. Clin. Psychol. 68, Chen, S., Barnett, P.G., Sempel, J.M., Timko, C., Outcomes and costs of matching the intensity of dual diagnosis treatment to patients symptom severity. J. Subst. Abuse Treat. 31, Chi, F.W., Satre, D.D., Weisner, C., Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes. Alcohol. Clin. Exp. Res. 30, Darke, S., Self-report among injecting drug users: a review. Drug Alcohol Depend. 51, DiMatteo, M.R., Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med. Care 42, Fureman, B., Parikh, G., Bragg, A., McLellan, T., Addiction Severity Index Fifth Edition: A Guide to Training and Supervising ASI Interviews Based on the Past Ten Years. Penn-VA Center for Studies of Addiction, Philadelphia. Garber, M.C., Nau, D.P., Erickson, S.R., Aikens, J.E., Lawrence, J.B., The concordance of self-report with other measures of medication adherence: a summary of the literature. Med. Care 42, Grella, C.E., Stein, J.A., Weisner, C., Moos, R., Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems. Drug Alcohol Depend. 110, Handymaker, N., Packard, M., Comforti, K., Motivational interviewing in the treatment of dual disorders. In: Miller, W.R., Rollnick, S. (Eds.), Motivational Interviewing: Preparing People for Change. Guilford Press, New York. Hensley, M.A., Evaluation of integrated treatment outcomes at Places for People. IJPR 8, Herman, H., Hawthorne, G., Thomas, R., Quality of life assessment in people living with psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 37, Hersh, D., Mulgrew, C.L., Van Kirk, J., Kranzler, H.R., The validity of self-reported cocaine use in two groups of cocaine abusers. J. Consult. Clin. Psychol. 67, Hien, D.A., Jiang, H., Campbell, A.N., Hu, M.C., Miele, G.M., Cohen, L.R., Brigham, G.S., Capstick, C., Kulaga, A., Robinson, J., Suarez-Morales, L., Nunes, E.V., Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from randomized clinical trial in NIDA s Clinical Trials Network. Am. J. Psychiatry 167, Humphreys, K., Clinicians referral and matching of substance abuse patients to self-help groups after treatment. Psychiatr. Serv. 48, Humphreys, K., Kaskutas, L.A., Weisner, C., The relationship of pretreatment Alcoholics Anonymous affiliation with problem severity, social resources, and treatment history. Drug Alcohol Depend. 49, Humphreys, K., Huebsch, P.D., Finney, J.W., Moos, R.H., A comparative evaluation of substance abuse treatment: V. Substance abuse treatment can enhance the effectiveness of self-help groups. Alcohol. Clin. Exp. Res. 23, Jordan, L.C., Davidson, W.S., Herman, S.E., Bootsmiller, B.J., Involvement in 12- step programs among persons with dual diagnoses. Psychiatr. Serv. 53, Kahler, C.W., Read, J.P., Ramsey, S.E., Stuart, G.L., McCrady, B.S., Brown, R.A., Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. J. Consult. Clin. Psychol. 72, Kaskutas, L.A., Subbaraman, M., Integrating addiction treatment and mutual aid recovery resources. In: Kelly, J.F., White, W.L. (Eds.), Addiction Recovery Management: Theory, Research and Practice. Springer, NY, pp Kelly, J.F., Yeterian, J.D., Mutual-help groups for dually diagnosed individuals: rationale, description, and review of the evidence. J. Groups Addict. Recover. 3, Kelly, J.F., McKellar, J.D., Moos, R., Major depression in patients with substance use disorders: relationship to 12-step self-help involvement and substance use outcomes. Addiction 98, Kirsner, B.R., Figuerdo, A.J., Jacobs, W.J., Self, friends, and lovers: Structural relations among Beck Depression Inventory scores and perceived mate values. J. Affect. Disord. 75, Laudet, A.B., The impact of Alcoholics Anonymous on other substance abuse related 12 step programs. Recent Dev. Alcohol. 18, Laudet, A.B., Magura, S., Cleland, C.M., Vogel, H.S., Knight, E.L., Rosenblum, A., The effect of 12-step-based fellowship participation on abstinence among dually diagnosed persons: a two-year longitudinal study. J. Psychoactive Drugs 36, Luke, D.A., Ribisl, K.M., Walton, M., Davidson II, W.S., Development and validation of the Addiction Belief Inventory. Subst. Use Misuse 37, Magura, S., Effectiveness of dual-focus mutual aid for co-occurring substance use and mental health disorders: a review and synthesis of the Double Trouble in recovery evaluation. Subst. Use Misuse 43, McKay, J.R., Alterman, A.I., McLellan, A.T., Snider, E.C., Treatment goals, continuity of care, and outcome in a day hospital substance abuse rehabilitation program. Am. J. Psychiatry 151, McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., Argeriou, M., 1985a. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9, McLellan, A.T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H.L., O Brien, C.P., 1985b. New data from the Addiction Severity Index: reliability and validity in three centers. J. Nerv. Ment. Dis. 173, Miller, W.R., Rose, G.S., Toward a theory of motivational interviewing. Am. Psychol. 65, Moos, R.H., Active ingredients of substance used-focused self-help groups. Addiction 103, Morgenstern, J., Labouvie, E., McCrady, B.S., Kahler, C.W., Frey, R.M., Affiliation with Alcoholics Anonymous after treatment: a study of its therapeutic effects and mechanisms of action. J. Consult. Clin. Psychol. 65, Mowbray, C.T., Solomon, M., Ribisl, K.M., Ebejer, M.A., Deiz, N., Brown, W., Bandla, H., Luke, D.A., Davidson II, W.S., Herman, S., Treatment for mental illness and substance abuse in a public psychiatric hospital: successful strategies and challenging problems. J. Subst. Abuse Treat. 12, Moyers, T.B., Martin, T., Christopher, P.J., Houck, J.M., Tonigan, J.S., Amrhein, P.C., Client language as a mediator of motivational interviewing efficacy: where is the evidence? Alcohol. Clin. Exp. Res. 31, 40s 47s. Moyers, T.B., Martin, T., Houck, J.M., Christopher, P.J., Tonigan, J.S., From in-session behaviors to drinking outcomes: a casual chain for motivational interviewing. J. Consult. Clin. Psychol. 77, Mueser, K.T., Glynn, S.M., Behavioral Family Therapy for Psychiatric Disorders. New Harbinger, Oakland, CA. Mueser, K., Noordsy, D., Drake, R., Fox, L., Integrated Treatment for Dual Disorders. Guilford Press, New York. Noordsy, D.L., Schwab, B., Fox, L., Drake, R.E., The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders. Community Ment. Health J. 32, Ortman, D., The Dual Diagnosis Recovery Sourcebook. NTC/Contemporary Publishing Group, Lincolnwood, IL. Ouimette, P., Humphreys, K., Moos, R.H., Finney, J.W., Cronkite, R., Federman, B., Self-help group participation among substance use disorder patients with posttraumatic stress disorder. J. Subst. Abuse Treat. 20, Ouimette, P.C., Finney, J.W., Moos, R.H., PTSD treatment and 5-year remission among patients with substance use and posttraumatic stress disorders. J. Consult. Clin. Psychol. 71,
8 C. Timko et al. / Drug and Alcohol Dependence 118 (2011) Read, J.P., Brown, P.J., Kahler, C.W., Substance use and posttraumatic stress disorders: symptom interplay and effects on outcome. Addict. Behav. 29, Ready, R.E., Watson, D., Clark, L.A., Psychiatric patient- and informant-reported personality: predicting concurrent and future behavior. Assessment 9, Rosenheck, R.A., Desai, R., Steinwachs, D., Lehman, A., Benchmarking treatment of schizophrenia: a comparison of service delivery by the national government and by state and local providers. J. Nerv. Ment. Dis. 188, Sacks, S., Chandler, R., Gonzales, J., 2008a. Responding to the challenges of cooccurring disorders. J. Subst. Abuse Treat. 34, Sacks, S., McKendrick, K., Sacks, J.Y., Banks, S., Harle, M., 2008b. Enhanced outpatient treatment for co-occurring disorders: main outcomes. J. Subst. Abuse Treat. 34, Satel, S.L., Becker, B.R., Dan, E., Reducing obstacles to affiliation with alcoholics anonymous among veterans with PTSD and alcoholism. Hosp. Community Psychiatry 44, Seal, K.H., Bertenthal, D., Miner, C.R., Marmar, C., Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. Arch. Intern. Med. 167, Seal, K.H., Maguen, S., Cohen, B., Gima, K.S., Metzler, T.J., Ren, L., Bertenthal, D., Marmar, C.R., VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses. J. Trauma. Stress 23, Shadish, W., Cook, T., Campbell, D., Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Houghton-Mifflin, Boston, MA. Sirey, J.A., Bruce, M.L., Alexopoulos, G.S., Perlick, D.A., Friedman, S.J., Meyers, B.S., Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr. Serv. 52, Thompson, K., Kulkarni, J., Sergejew, A.A., Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr. Res. 42, Timko, C., DeBenedetti, A., A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes. Drug Alcohol Depend. 90, Timko, C., Sempel, J.M., Intensity of acute services, self-help attendance and one-year outcomes among dual diagnosis patients. J. Stud. Alcohol 65, Tonigan, J.S., Connors, G.J., Miller, W.R., Alcoholics Anonymous Involvement Scale: reliability and norms. Psychol. Addict. Behav. 10, Tonigan, J.S., Connors, G.J., Miller, W.R., 2002a. Participation and involvement in Alcoholics Anonymous. In: Babor, T.F., Del Boca, F.K., Edwards, G. (Eds.), Treatment Matching in Alcoholism (International Research Monographs in the Addictions). University Press, Cambridge, UK. Tonigan, J.S., Miller, W.R., Juarez, P., Villanueva, M., 2002b. Utilization of AA by hispanic and non-hispanic white clients receiving outpatient alcohol treatment. J. Stud. Alcohol 63, Voruganti, L., Heslegrave, R., Awad, A.G., Seeman, M.V., Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol. Med. 28, Walitzer, K.S., Dermen, K.H., Barrick, C., Facilitating involvement in Alcoholics Anonymous during outpatient treatment: a randomized clinical trial. Addiction 104, Westermeyer, J., Comorbid schizophrenia and substance abuse: a review of epidemiology and course. Am. J. Addict. 15, Westermeyer, J.J., Schneekloth, T.D., Course of substance abuse patients with and without schizophrenia. Am. J. Addict. 8,
A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes
Drug and Alcohol Dependence 90 (2007) 270 279 A randomized controlled trial of intensive referral to 2-step self-help groups: One-year outcomes Christine Timko a,, Anna DeBenedetti b a Center for Health
More informationSpecial Populations in Alcoholics Anonymous. J. Scott Tonigan, Ph.D., Gerard J. Connors, Ph.D., and William R. Miller, Ph.D.
Special Populations in Alcoholics Anonymous J. Scott Tonigan, Ph.D., Gerard J. Connors, Ph.D., and William R. Miller, Ph.D. The vast majority of Alcoholics Anonymous (AA) members in the United States are
More informationIntensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes
Original Article Intensive referral to 12-Step self-help Christine Timko et al. RESEARCH REPORT doi:10.1111/j.1360-0443.2006.01391.x Intensive referral to 12-Step self-help groups and 6-month substance
More informationThe Role of Mutual Help Groups in Extending the Framework of Treatment. John F. Kelly, Ph.D., and Julie D. Yeterian
The Role of Mutual Help Groups in Extending the Framework of Treatment John F. Kelly, Ph.D., and Julie D. Yeterian Alcohol use disorders (AUDs) are highly prevalent in the United States and often are chronic
More informationObservational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction STUDY PROTOCOL
Observational study of the long-term efficacy of ibogaine-assisted therapy in participants with opioid addiction Purpose and Objectives STUDY PROTOCOL This research is an investigator-sponsored observational
More informationQ&A. What Are Co-occurring Disorders?
What Are Co-occurring Disorders? Some people suffer from a psychiatric or mental health disorder (such as depression, an anxiety disorder, bipolar disorder, or a mood or adjustment disorder) along with
More information9/25/2015. Parallels between Treatment Models 2. Parallels between Treatment Models. Integrated Dual Disorder Treatment and Co-occurring Disorders
Integrated Dual Disorder Treatment and Co-occurring Disorders RANDI TOLLIVER, PHD HEARTLAND HEALTH OUTREACH, INC. ILLINOIS ASSOCIATION OF PROBLEM-SOLVING COURTS OCTOBER 8, 2015 SPRINGFIELD, IL Parallels
More informationFRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment
FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment Background Studies show that more than 50% of patients who have been diagnosed with substance abuse
More informationTreatment of Alcohol Dependence With Psychological Approaches
Treatment of Alcohol Dependence With Psychological Approaches A broad range of psychological therapies and philosophies currently are used to treat alcoholism, as noted in a recent review (Miller et al.
More informationAA - APA Webinar 5/2014 1
THE PSYCHOLOGY OF AA AND NA AND THEIR ROLE IN CLINICAL CARE Marc Galanter, M.D. Professor of Psychiatry and Director Division of Alcoholism and Drug Abuse NYU School of Medicine Dr. Galanter has no conflicts
More informationActive ingredients of substance use-focused self-help groups
REVIEW doi:10.1111/j.1360-0443.2007.02111.x Active ingredients of substance use-focused self-help groups Rudolf H. Moos Center for Health Care Evaluation, Department of Veterans Affairs and Stanford University,
More informationNational Addiction Centre, Maudsley Hospital/Institute of Psychiatry, King s College London, London, UK
RESEARCH REPORT doi:10.1111/j.1360-0443.2007.02050.x Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment
More informationRole of Self-help Group in Substance Addiction Recovery
International Journal of Advancements in Research & Technology, Volume 1, Issue6, November-2012 1 Role of Self-help Group in Substance Addiction Recovery Dr. Prangya Paramita Priyadarshini Das -------------------------------------------------------------------------------------------------------------------
More informationYOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT
YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT Siobhan A. Morse, MHSA, CRC, CAI, MAC Director of Fidelity and Research Foundations Recovery Network YOUNG
More informationUNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015
UNDERSTANDING CO-OCCURRING DISORDERS Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015 CO-OCCURRING DISORDERS What does it really mean CO-OCCURRING
More informationSubstance Abuse in Brief Fact Sheet
An Introduction to Mutual Support Groups for Alcohol and Drug Abuse Mutual support (also called self-help) groups are an important part of recovery from substance use disorders (SUDs). Mutual support groups
More informationinformation for service providers Schizophrenia & Substance Use
information for service providers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 2 3 5 6 7 8 9 How prevalent are substance use disorders among people with schizophrenia? How prevalent
More informationIS ATTENDANCE AT ALCOHOLICS ANONYMOUS MEETINGS AFTER INPATIENT TREATMENT RELATED TO IMPROVED OUTCOMES? A 6-MONTH FOLLOW-UP STUDY
Alcohol & Alcoholism Vol. 38, No. 5, pp. 421 426, 2003 doi:10.1093/alcalc/agg104, available online at www.alcalc.oupjournals.org IS ATTENDANCE AT ALCOHOLICS ANONYMOUS MEETINGS AFTER INPATIENT TREATMENT
More informationCurrent Models of Recovery Support Services: Where We Have Data and Where We Don t
Current Models of Recovery Support Services: Where We Have Data and Where We Don t Richard Rawson, Ph.D. Integrated Substance Abuse Programs University of California, Los Angeles 1. Define recovery Talk
More informationClinical Perspective on Continuum of Care in Co-Occurring Addiction and Severe Mental Illness. Oleg D. Tarkovsky, MA, LCPC
Clinical Perspective on Continuum of Care in Co-Occurring Addiction and Severe Mental Illness Oleg D. Tarkovsky, MA, LCPC SAMHSA Definition Co-occurring disorders may include any combination of two or
More informationPhoenix House. Outpatient Treatment Services for Adults in Los Angeles and Orange Counties
Phoenix House Outpatient Treatment Services for Adults in Los Angeles and Orange Counties Phoenix House s outpatient programs offer comprehensive and professional clinical services that include intervention,
More informationHave we evaluated addiction treatment correctly? Implications from a chronic care perspective
EDITORIAL Have we evaluated addiction treatment correctly? Implications from a chronic care perspective The excellent reviews of alcohol treatment outcomes and methods for evaluating and comparing treatment
More informationKeith Humphreys. Circles of Recovery: Mutual help Organizations for Substance Use Disorders
Circles of Recovery: Mutual help Organizations for Substance Use Disorders 31 March 2015 School of Social Service Administration University of Chicago Keith Humphreys Professor of Psychiatry, Stanford
More informationPerformance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
More informationAddiction self-help organizations: Research findings and policy options
Addiction self-help organizations: Research findings and policy options Keith Humphreys, Ph.D. Director, VA Program Evaluation and Resource Center Associate Professor of Psychiatry, Stanford University
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,
More informationFRN Research Report August 2011 Patient Outcomes and Relapse Prevention Up to One Year Post- Treatment at La Paloma Treatment Center
Page 1 FRN Research Report August 2011 Patient Outcomes and Relapse Prevention Up to One Year Post- Treatment at La Paloma Treatment Center Background La Paloma Treatment Center offers state-of-the art
More informationPatient Satisfaction Scores
Patient Satisfaction Scores FRN Research Report September 2013 Introduction There are good reasons for health care stakeholders to value patient satisfaction scores. Satisfaction data provide important
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationAdolescents, Young Adults and Recovery Support Groups: Science-grounded Principles for Probation Officers. William L. White, MA
Adolescents, Young Adults and Recovery Support Groups: Science-grounded Principles for Probation Officers William L. White, MA Every one seems to have an opinion about the need for or appropriateness of
More informationPERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment
UPDATED 4.6.2015 PERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment Psychosocial interventions are structured psychological or social interventions used to address substance-related
More informationEffects of Distance to Treatment and Treatment Type on Alcoholics Anonymous Attendance and Subsequent Alcohol Consumption. Presenter Disclosure
Effects of Distance to Treatment and Treatment Type on Alcoholics Anonymous Attendance and Subsequent Alcohol Consumption Jamie L. Heisey, MA Katherine J. Karriker-Jaffe, PhD Jane Witbrodt, PhD Lee Ann
More informationRates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs
Rates of Trauma-Informed Counseling at Substance Abuse Treatment Facilities: Reports From Over 10,000 Programs Nicole M. Capezza, Ph.D. Lisa M. Najavits, Ph.D. Objective: Trauma-informed treatment increasingly
More informationTreatment Research Institute 600 Public Ledger Building, 150 S. Independence Mall West Philadelphia, PA 19106-3475 (800 )238-2433
From The University of Pennsylvania/Veterans Administration Center for Studies of Addiction Supported by Grants from the National Institute of Drug Abuse(project DA 02254) and the Veterans Administration
More informationDo patient intervention ratings predict alcohol-related consequences?
Addictive Behaviors 32 (2007) 3136 3141 Short communication Do patient intervention ratings predict alcohol-related consequences? Christina S. Lee a,, Richard Longabaugh a, Janette Baird b, Ana M. Abrantes
More informationEffectiveness of Treatment The Evidence
Effectiveness of Treatment The Evidence The treatment programme at Castle Craig is based on the 12 Step abstinence model. This document describes the evidence for residential and 12 Step treatment programmes.
More informationCo-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
More informationMutual help, recovery and addiction: A research and policy perspective
Mutual help, recovery and addiction: A research and policy perspective Presented 4 May 2012 to UK RCP Faculty of Addictions Cardiff, Wales Professor Keith Humphreys Veterans Affairs and Stanford University
More informationDDCAT Top Rating Shows Ongoing Commitment to Superior Services
FRN Research Report: July 2013 DDCAT Top Rating Shows Ongoing Commitment to Superior Services Background Foundations Recovery Network, headquartered in Nashville, Tenn., operates nine addiction treatment
More informationThe efficacy of a relapse prevention programme in the treatment of heroin dependence in China
The efficacy of a relapse prevention programme in the treatment of heroin dependence in China Zhao Min 1, Li Xu 1, Wang Zhu-cheng 1, Xu Ding 2, Zhang Yi 2, Zhang Ming-yuang 1 1 Shanghai Mental Health Centre
More informationLisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis, MD, MPH
CBT for Youth with Co-Occurring Post Traumatic Stress Disorder and Substance Disorders Lisa R. Fortuna, MD, MPH Michelle V. Porche, Ed. D Sripallavi Morampudi, MBBS Stanley Rosenberg, PhD Douglas Ziedonis,
More informationRecovery Outcomes for Opiate Users. FRN Research Report November 2013
Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers
More informationComprehensive Addiction Treatment
Comprehensive Addiction Treatment A cognitive-behavioral approach to treating substance use disorders Brief Treatment Eric G. Devine Deborah J. Brief George E. Horton Joseph S. LoCastro Comprehensive Addiction
More informationMinnesota Co-occurring Mental Health & Substance Disorders Competencies:
Minnesota Co-occurring Mental Health & Substance Disorders Competencies: This document was developed by the Minnesota Department of Human Services over the course of a series of public input meetings held
More informationUtilization of the Electronic Medical Record to Assess Morbidity and Mortality in Veterans Treated for Substance Use Disorders
Utilization of the Electronic Medical Record to Assess Morbidity and Mortality in Veterans Treated for Substance Use Disorders Dr. Kathleen P. Decker, M.D. Staff Psychiatrist, Hampton VAMC Assistant Professor,
More informationPOLL. Co-occurring Disorders: the chicken or the egg. Objectives
Co-occurring Disorders: the chicken or the egg Christopher W. Shea, MA, CRAT, CAC-AD Clinical Director Father Martin s Ashley Havre de Grace, Maryland chrismd104@yahoo.com Objectives To identify what is
More informationinformation for families Schizophrenia & Substance Use
information for families Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 3 5 6 7 8 9 10 Why do people with schizophrenia use drugs and alcohol? What is the impact of using substances
More informationPeers in Co-Occurring Services: Impact on Fidelity. Jennifer Harrison, LMSW, CAADC Jennifer.harrison@wmich.edu
Peers in Co-Occurring Services: Impact on Fidelity Jennifer Harrison, LMSW, CAADC Jennifer.harrison@wmich.edu Introduction Co-Occurring Disorders >50% with a Serious Mental Illness (SMI) also have a Substance
More informationARTICLE IN PRESS. Predicting alcohol and drug abuse in Persian Gulf War veterans: What role do PTSD symptoms play? Short communication
DTD 5 ARTICLE IN PRESS Addictive Behaviors xx (2004) xxx xxx Short communication Predicting alcohol and drug abuse in Persian Gulf War veterans: What role do PTSD symptoms play? Jillian C. Shipherd a,b,
More informationThe methodology for treating
Continuity of Care in a VA Substance Abuse Treatment Program Elie M. Francis, MD; Joseph DeBaldo, MBA, MEd; Suzanne E. Shealy, PhD; and Cheryl L. Gonzales-Nolas, MD Continuous care is essential to successful
More informationSCIACCA COMPREHENSIVE SERVICE DEVELOPMENT FOR MENTAL ILLNESS, DRUG ADDICTION & ALCOHOLISM *MIDAA(R)
SCIACCA COMPREHENSIVE SERVICE DEVELOPMENT FOR MENTAL ILLNESS, DRUG ADDICTION & ALCOHOLISM *MIDAA(R) CURRICULUM for MICAA and CAMI DIRECT CARE PROVIDERS: MENTAL ILLNESS, DRUG ADDICTION and ALCOHOLISM MIDAA(R).and
More informationSchizoaffective Disorder
FACT SHEET 10 What Is? Schizoaffective disorder is a psychiatric disorder that affects about 0.5 percent of the population (one person in every two hundred). Similar to schizophrenia, this disorder is
More informationFRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
More informationThe Field of Counseling. Veterans Administration one of the most honorable places to practice counseling is with the
Gainful Employment Information The Field of Counseling Job Outlook Veterans Administration one of the most honorable places to practice counseling is with the VA. Over recent years, the Veteran s Administration
More informationTreating Co-Occurring Disorders. Stevie Hansen, B.A., LCDC, NCACI Chief, Addiction Services
Treating Co-Occurring Disorders Stevie Hansen, B.A., LCDC, NCACI Chief, Addiction Services Implementing SAMHSA Evidence-Based Practice Toolkits Integrated Dual Diagnosis Treatment (IDDT) Target group:
More informationOXFORD HOUSE: DEAF-AFFIRMATIVE SUPPORT
OXFORD HOUSE: DEAF-AFFIRMATIVE SUPPORT FOR SUBSTANCE ABUSE RECOVERY DEAF JOSEFINA ALVAREZ, ADERONKE M. ADEBANJO, MICHELLE K. DAVIDSON, LEONARD A. JASON, AND MARGARET I. DAVIS ALVAREZ IS A RESEARCH ASSOCIATE,
More informationHigh effectiveness of self-help programs after drug addiction therapy
High effectiveness of self-help programs after drug addiction therapy John-Kåre Vederhus 1, Øistein Kristensen 1 1 Addiction Unit, Sørlandet Hospital, Kristiansand, Norway E-mail addresses: JKV: john-kare.vederhus@sshf.no
More informationParticipation in Treatment and Alcoholics Anonymous: A 16-Year Follow-Up of Initially Untreated Individuals
Participation in Treatment and Alcoholics Anonymous: A 16-Year Follow-Up of Initially Untreated Individuals Rudolf H. Moos and Bernice S. Moos Center for Health Care Evaluation, Department of Veterans
More informationMark P. McGovern, PhD, 1 Chantal Lambert-Harris, MA, 2 Arthur I. Alterman, PhD, 3 Haiyi Xie, PhD, 4 and Andrea Meier, MS 2
JOURNAL OF DUAL DIAGNOSIS, 7(4), 207 227, 2011 Copyright C Taylor & Francis Group, LLC ISSN: 1550-4263 print / 1550-4271 online DOI: 10.1080/15504263.2011.620425 A Randomized Controlled Trial Comparing
More informationConsumers Experiences in Dual Focus Mutual Aid for Co-occurring Substance Use and Mental Health Disorders
Substance Abuse: Research and Treatment Original Research Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Consumers Experiences in Dual Focus Mutual Aid for
More informationHow To Know What You Use For Treatment Of Substance Abuse
National Survey of Substance Abuse Treatment Services The N-SSATS Report October 14, 010 Clinical or Therapeutic Approaches Used by Substance Abuse Treatment Facilities In Brief In 009, the majority of
More informationA Preliminary Analysis of the Orange County DUI Court
A Preliminary Analysis of the Orange County DUI Court Carrie J. Petrucci, Ph.D. cpetruc@calstatela.edu Elizabeth Piper Deschenes, Ph.D. libby@csulb.edu October 21 st, 2005 1 Outline of Presentation Evidence
More informationMichelle D. Sherman, Ph.D.
Michelle D. Sherman, Ph.D. Director, OKC VAMC Family Mental Health Program Clinical Professor, University of Oklahoma Health Sciences Center, Core Investigator, South Central MIRECC Overview 1. Rationale
More informationMental Illness and Substance Abuse. Eric Goldberg D.O.
Mental Illness and Substance Abuse Eric Goldberg D.O. Objectives Item 1 Define and understand Co-Occurring Disorder (COD) Item 2 Item 3 Item 4 Define substance abuse, substance dependence and, Substance
More informationPhysicians in Long Term Recovery Who Are Members of Alcoholics Anonymous
The American Journal on Addictions, 22: 323 328, 2013 Copyright American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/j.1521-0391.2013.12051.x Physicians in Long
More informationDual Diagnosis. Location: VA Boston Healthcare System, Brockton Campus
Track Director: Justin Enggasser, Ph.D. Psychology Service (116B) 940 Belmont Street Brockton, MA 02301 Telephone: (774) 826-1380 Email: justin.enggasser@va.gov Dual Diagnosis Location: VA Boston Healthcare
More informationStructured intervention in preparing dependent drinkers towards abstinence Windmill Team Alcohol Care Pathway evaluation. May 2014
45 Structured intervention in preparing dependent drinkers towards abstinence Windmill Team Alcohol Care Pathway evaluation. May 2014 E. Sharma, A. Smith, K.J. Charge and C. Kouimtsidis Windmill Drug &
More informationRecovery and Dual Diagnosis
Recovery and Dual Diagnosis Martha Levey, Ed.D. Affiliated Service Providers of Indiana, Inc. The mission of ASPIN is to provide innovative educational programs, resource management, program development,
More informationLEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American
More informationIntegrated Dual Disorders Treatment Fidelity Scale
IDDT Fidelity Scale Protocol (Revision of 11-272-02) Page 1 Integrated Dual Disorders Treatment Fidelity Scale This document is intended to help guide you in administering the Integrated Dual Disorders
More informationFrequently Asked Questions About Prescription Opioids
Mental Health Consequences of Prescription Drug Addictions Opioids, Hypnotics and Benzodiazepines Learning Objectives 1. To review epidemiological data on prescription drug use disorders Ayal Schaffer,
More informationOutcomes of AA for Special Populations. Christine Timko, Ph.D.
Outcomes of AA for Special Populations Christine Timko, Ph.D. Research Career Scientist and Consulting Professor, Center for Health Care Evaluation (152-MPD), VA Health Care System, 795 Willow Road, Menlo
More informationIntegrated Dual Diagnosis Treatment Stagewise Treatment Interventions and Activities
Integrated Dual Diagnosis Treatment Stagewise Treatment Interventions and Activities Dartmouth Dual Diagnosis Treatment Scale Evidenced Based Interventions Stage-Wise Activities for Case Managers Activities
More informationAlcohol and Drug Counseling
108 Alcohol and Drug Counseling Alcohol and Drug Counseling Degrees, Certificates and Awards Associate in Arts: Alcohol and Drug Counseling Certificate of Achievement: Alcohol and Drug Counseling Certificate
More informationtreatment effectiveness and, in most instances, to result in successful treatment outcomes.
Key Elements of Treatment Planning for Clients with Co Occurring Substance Abuse and Mental Health Disorders (COD) [Treatment Improvement Protocol, TIP 42: SAMHSA/CSAT] For purposes of this TIP, co occurring
More informationSubstance Abuse Treatment, Prevention, and Policy 2012, 7:37
Substance Abuse Treatment, Prevention, and Policy This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available
More informationinformation for consumers Schizophrenia & Substance Use
information for consumers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 3 4 5 6 7 Why do people with schizophrenia use drugs and alcohol? How can using substances affect you if
More informationMental Health 101 for Criminal Justice Professionals David A. D Amora, M.S.
Mental Health 101 for Criminal Justice Professionals David A. D Amora, M.S. Director, National Initiatives, Council of State Governments Justice Center Today s Presentation The Behavioral Health System
More informationTreatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
More informationClinical Treatment Protocol For The Integrated Treatment of Pathological Gamblers. Presented by: Harlan H. Vogel, MS, NCGC,CCGC, LPC
Clinical Treatment Protocol For The Integrated Treatment of Pathological Gamblers Presented by: Harlan H. Vogel, MS, NCGC,CCGC, LPC Purpose of Presentation To provide guidelines for the effective identification,
More informationClinical Training Guidelines for Co-occurring Mental Health and Substance Use Disorders
Winnipeg Region Co-occurring Disorders Initiative Clinical Training Guidelines for Co-occurring Mental and Substance Use Disorders September 2003 Clinical Training Guidelines for Co-occurring Mental and
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationPERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment
UPDATED 31.5.2016 PERSPECTIVES ON DRUGS The role of psychosocial interventions in drug treatment Psychosocial interventions are structured psychological or social interventions used to address substance-related
More informationChronic Pain in Patients with Alcohol or Drug Use Disorders. Mark Ilgen Elizabeth Haas Linda Webster Stephen Chermack Kristen Barry Frederic Blow
Chronic Pain in Patients with Alcohol or Drug Use Disorders Mark Ilgen Elizabeth Haas Linda Webster Stephen Chermack Kristen Barry Frederic Blow Overview Background information on overlap between pain
More information12 Steps to Changing Neuropathways. Julie Denton
12 Steps to Changing Neuropathways Julie Denton Review the neurobiology of the brain Understand the basics of neurological damage to the brain from addiction Understand how medications and psychotherapy
More informationSusan Littrell, LICSW, LADC, Certified Co-Occurring Disorders Professional Diplomate Hennepin County Community Outreach for Psychiatric Emergencies
Susan Littrell, LICSW, LADC, Certified Co-Occurring Disorders Professional Diplomate Hennepin County Community Outreach for Psychiatric Emergencies (COPE) Discuss the prevalence of co-occurring disorders
More informationOverview of Chemical Addictions Treatment. Psychology 470. Background
Overview of Chemical Addictions Treatment Psychology 470 Introduction to Chemical Additions Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides 1 Background Treatment approaches
More informationTHE UNIVERSITY OF TENNESSEE COLLEGE OF SOCIAL WORK. 616 Advanced EBP for Addictions and Dual Diagnosis Treatment (3) Fall 2014
THE UNIVERSITY OF TENNESSEE COLLEGE OF SOCIAL WORK 616 Advanced EBP for Addictions and Dual Diagnosis Treatment (3) Fall 2014 Instructor: R. Lyle Cooper, Ph.D., LCSW Phone: 615-431-2125 (home between 9-7
More informationHow. HOLiSTIC REHAB. Benefits You
How HOLiSTIC REHAB Benefits You Table of Content Holistic Rehab Centers are More Popular than Ever The Need for Drug & Alcohol Rehabilitation Programs Alcohol Abuse and Addiction These Issues Need Treatment
More informationFixing Mental Health Care in America
Fixing Mental Health Care in America A National Call for Measurement Based Care in Behavioral Health and Primary Care An Issue Brief Released by The Kennedy Forum Prepared by: John Fortney PhD, Rebecca
More informationDual Diagnosis and Integrated Treatment of Mental Illness and Substance Abuse Disorder
Dual Diagnosis and Integrated Treatment of Mental Illness and Substance Abuse Disorder What are dual diagnosis services? Dual diagnosis services are treatments for people who suffer from co-occurring disorders
More informationDelivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)
Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Learning Objectives Upon completion of this module, you should be able to: Describe how
More informationWhite, W. (2013). The science of addiction recovery mutual aid: An interview with John F. Kelly, PhD. Posted at www.williamwhitepapers.
White, W. (2013). The science of addiction recovery mutual aid: An interview with John F. Kelly, PhD. Posted at www.williamwhitepapers.com Introduction The Science of Addiction Recovery Mutual Aid: An
More informationCo-Occurring Disorders
Co-Occurring Disorders Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1: Introduction Early studies conducted in substance abuse programs typically
More informationAbstinence trajectories among treated crack cocaine users
Addictive Behaviors 27 (2002) 437 449 Abstinence trajectories among treated crack cocaine users Harvey A. Siegal*, Li Li, Richard C. Rapp Center for Interventions, Treatment, and Addictions Research, Wright
More informationTHE INTEGRATED DUAL DIAGNOSIS TREATMENT PROGRAM OF VENTURA COUNTY BEHAVIORAL HEALTH. Presented by Linda Gertson, Ph.D. Behavioral Health Manager
THE INTEGRATED DUAL DIAGNOSIS TREATMENT PROGRAM OF VENTURA COUNTY BEHAVIORAL HEALTH Presented by Linda Gertson, Ph.D. Behavioral Health Manager The California Institute of Mental Health (CIMH) was awarded
More informationIntegrating Treatment For Co-occurring Disorders SCREENING & ASSESSMENT
Integrating Treatment For Co-occurring Disorders SCREENING & ASSESSMENT Integrating Treatment for Co-Occurring Disorders Brought to you by: Effective Treatment CLIENT FACTORS 40% THERAPY RELATIONSHIP 30%
More informationTHE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
More informationDEPARTMENT OF PSYCHIATRY. 1153 Centre Street Boston, MA 02130
DEPARTMENT OF PSYCHIATRY 1153 Centre Street Boston, MA 02130 Who We Are Brigham and Women s Faulkner Hospital (BWFH) Department of Psychiatry is the largest clinical psychiatry site in the Brigham / Faulkner
More information5 keys to improve counseling for dual-diagnosis patients
5 keys to improve counseling for dual-diagnosis patients An empathic approach can be effective when treating psychiatric patients with substance use disorders 40 VOL. 2, NO. 9 / SEPTEMBER 2003 Sumita G.
More information